$4550
[Research Report] The dental bone graft substitutes and barrier membrane market was valued at US$ 722.04 million in 2022 and is expected to reach US$ 1,379.92 million by 2030; it is estimated to record a CAGR of 8.4% from 2022 to 2030.
Market Insights and Analyst View:
Dental membranes are used for guided tissue regeneration (GTR) and guided bone regeneration (GBR). Different dental membranes are commercially available, and innovative membranes have been developed extensively. Dental barrier membranes are generally required to provide barrier function, biosafety, biocompatibility, and appropriate mechanical properties. In addition, membranes are supposed to be bioactive in nature, promoting tissue regeneration. On the other hand, dental bone graft substitute is a natural or synthetic material, often containing only a mineralized bone matrix with no viable cells. In the near future, alloplastic bone substitutes with safety and standardized quality may be the first choice instead of autologous bone; they may offer new osteoconductive and osteoinductive products with easier handling form and an adequate resorption rate, which can be used with growth factors and/or cell transplantation. Careful selection of alloplastic bone graft products is necessary to achieve favourable outcomes according to each clinical situation. Dental bone graft materials have been commonly used with growth factors and/or barrier membranes in situations such as periodontal regeneration therapies and guided bone regeneration procedures before implant placements. In recent past, these materials have also been applied to bone defects caused by peri-implantitis.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Growth Drivers and Challenges:
According to British Dental Journal, approximately 10–12% of cases of inflammatory maxillary sinus disease are of dental origin. Mostly, these diseases are not only related to pulpal necrosis and periapical disease but also advanced periodontal disease and oro-antral communications following dento-alveolar surgery. Extruded pulp space-filling materials will act as local irritants when displaced into the maxillary sinus, and have predisposed to fungal infections such as aspergillosis. Both autologous bone and various bone substitutes have been studied in the last decades as grafting materials for maxillary sinus floor elevation. Recently, xenogeneic and alloplastic bone substitutes in gel form have been proposed as grafting material for transcrestal sinus floor elevation. These biomaterials are composed of micronized particles (generally up to 300 μm) suspended in an aqueous solution and embedded in a collagen matrix. These biomaterials are easily injectable into the subantral space after performing a crestal access to the sinus cavity through the cortical of the sinus floor. Micronized particles are smooth and do not present sharp or cutting edges, representing a risk factor for sinus membrane tearing during grafting procedures. Additionally, bone substitutes in gel form accidentally dispersed into the sinus cavity could be more easily cleared through the OMC by the ciliary activity due to the pasty consistency and the extremely small dimensions of the particles. Such factors have assisted the growth of the global dental bone graft substitutes and barrier membrane market and is expected to continue to follow a similar trend during the forecast period. Periodontal diseases range from simple gingivitis to serious conditions that cause significant damage to the soft tissues and bones that support teeth; in the worst case, teeth are lost. Periodontal disease is a major public health problem in the US, and many adults in the country currently have some form of this disease. A study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research (AACR), showed that periodontal disease is associated with an increased risk of multiple cancers in postmenopausal women. According to the article “The Link between Periodontal Disease and Oral Cancer—A Certainty or a Never-Ending Dilemma” published in the Multidisciplinary Digital Publishing Institute (MDPI), more than 50% population, including 18-year-old adults, in the US has periodontitis, and 75% of the population over 35 has some form of periodontitis. The severity of periodontitis is also variable. According to different studies, 30–50% of these diseases are mild, and 5–15% are severe and generalized.
In the US, a national health interview survey has reported a high prevalence of periodontitis based on oral health assessments; the prevalence of periodontitis among adults older than 30 is estimated at ~47%, rising to 70% in those aged 65 and above. The prevalence of moderate and severe periodontitis, more closely associated with systemic inflammation and the immune response, is significantly high in adults over 65.
Cancer is one of the major public health concerns and the second-leading cause of death in the US. According to the US Department of Health and Human Services, oral cancer accounts for ~3% of cancer cases diagnosed annually in the US. Yearly, ~48,000 people are diagnosed with oral cancer, and ~9,600 succumb to death due to this condition. According to the CDC, mouth and throat cancer cases account for 3% of cancer cases diagnosed annually in the US in 2020. Risk factors for oral cancer include tobacco use, excessive alcohol consumption, and HPV infection. Periodontal disease can lead to resorption and failure of the alveolar bone, loss of periodontal attachment, and loosening and falling of the teeth. Therefore, the treatment of periodontal disease focuses on eliminating the source of infection, stimulating factors, and pays attention to repairing periodontal tissue defects and restoring normal morphology and function. Bone grafting is done for repairing periodontal defects by grafting materials (bone or bone substitutes) to restore the anatomical morphology of the alveolar bone and the function of the periodontal tissue. Therefore, the growing cases of periodontal diseases and oral cancer contribute to the growth of the dental bone graft substitutes and barrier membrane market.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Dental Bone Graft Substitutes and Barrier Membrane Market: Strategic Insights
Market Size Value in US$ 722.04 million in 2022 Market Size Value by US$ 1,379.92 million by 2030 Growth rate CAGR of 8.4% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Dental Bone Graft Substitutes and Barrier Membrane Market: Strategic Insights

Market Size Value in | US$ 722.04 million in 2022 |
Market Size Value by | US$ 1,379.92 million by 2030 |
Growth rate | CAGR of 8.4% from 2022 to 2030 |
Forecast Period | 2022-2030 |
Base Year | 2022 |

Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Report Segmentation and Scope:
The global dental bone graft substitutes and barrier membrane market, based on product, is bifurcated into dental bone graft substitutes and dental barrier membrane. Dental bone graft substitutes are segmented into allograft, xenograft, synthetic bone graft, aDental bone graft substitutes are segmented into allograft, xenograft, synthetic bone graft, and others. On the other hand, dental barrier membrane is divided into resorbable membrane and non-resorbable membrane. Based on procedure, the dental bone graft substitutes and barrier membrane market is segmented into guided bone regeneration procedures (GBR), guided tissue regeneration procedures (GTR), sinus-lift procedures and ridge-split procedures, alveolar ridge preservation (ARP), block-graft procedures, periodontal regeneration procedures, socket preservation, and others. Based on end user, the dental bone graft substitutes and barrier membrane market is segmented into hospital, dental clinics, and others. Based on geography, the dental bone graft substitutes and barrier membrane market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Segmental Analysis:
The global dental bone graft substitutes and barrier membrane market, based on end user, is segmented into hospitals, dental clinics, and others. In 2022, the dental clinics segment held the largest market share and is expected to register the highest CAGR during the forecast period. In the US, the penetration of dental clinics is more compared to hospitals. Demographically, this may vary slightly in emerging and developing countries, but the penetration or share of dental clinics is more compared to hospitals across the world. According to Express Dentist, in 2021, there were 159,246 dentists licensed for general practice in the US and 10,921 were licensed for orthodontics and dentofacial orthopedics. Rising geriatric population and increasing number of cosmetic dentistry procedures in the US have also assisted the overall market growth and are expected to continue to catalyze the overall dental bone graft substitutes and barrier membrane market during the forecast period.
Dental Bone Graft Substitutes and Barrier Membrane Market, by End User – 2022 and 2030
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Regional Analysis:
North America is the dominating region in the dental bone graft substitutes and barrier membrane market. The North America dental bone graft substitutes and barrier membrane market was valued at US$ 293.65 million in 2022 and is projected to reach US$ 552.38 million by 2030; it is expected to register a CAGR of 8.2% during the forecast period. The North America dental bone graft substitutes and barrier membrane market is segmented into the US, Canada, and Mexico. The US captured the largest share in 2022 and is expected to continue with a similar trend during the forecast period. According to the American Dental Association, the demographic of older adults (i.e., 65 years of age and older) is growing and likely will be an increasingly large part of dental practice in the coming years. Dental conditions associated with aging include dry mouth (xerostomia), root and coronal caries, and periodontitis. According to the National Institute of Dental and Craniofacial Research, 30% of adults (i.e., 65 years or older) in the US had total periodontitis, 7.8% with severe periodontitis, and 34.4% with non-severe periodontitis. Such a factor has aided the regional growth of dental bone graft substitutes and barrier membrane market and is expected to continue with a similar trend during the forecast period.
Competitive Landscape and Key Companies:
Dentsply Sirona, Johnson & Johnson, Danaher Corporation, Medtronic, Strauman, Zimmer Dental, Smith & Nephew, Geistlich Pharm, ZimVie Inc., RTI Surgical, and Osteogenics Biomedical are among the leading companies operating in the global dental bone graft substitutes and barrier membrane market.
Among these players, Medtronic and Geistlich Pharm are the top two players owing to the diversified product portfolio offered by them.
Krey Developments:
Inorganic and organic strategies such as mergers and acquisitions are highly adopted by companies in the dental bone graft substitutes and barrier membrane market. A few recent key market developments are listed below:
- In March 2023, ZimVie Inc. announced the release of its publication 'Comparison of the Effects of Tissue Processing on the Physicochemical Properties of Bone Allografts.' The article was published in The International Journal of Oral & Maxillofacial Implants. The article showed the impact of different tissue processing methods of its products, such as Puros Cancellous Particulate Allograft bone substitute, Creos, OraGraft, and MinerOss.
- In January 2021, Dentsply Sirona announced the acquisition of Datum Dental, Ltd. The acquisition enabled Dentsply Sirona to acquire a strong OSSIX biomaterial portfolio of Datum Dental, Ltd. It has also enabled the acquisition of Datum Dental Ltd's patented technology GLYMATRIX.
Covid-19 Impact:
The COVID-19 crisis significantly decreased the adoption of dental bone graft substitutes and barrier membranes due to low patient volumes in dental clinics and hospitals. Prominent market participants witnessed a significant drop in their revenues and profit margins during the COVID-19 crisis. The decline in dental visits and delay in elective surgeries directly impacted the bone graft substitutes and dental barrier membrane products market. In short, the demand from end users has declined significantly as key regions and countries imposed social distancing rules and lockdowns to limit the spread of the virus. Thus, the pandemic negatively impacted the market growth of dental bone graft substitutes and barrier membrane. However, the relaxation of regulations in 2022 led to increased admissions in dental hospitals and specialty clinics.

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Product, Procedure, End User, and Geography

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
This text is related
to country scope.
Frequently Asked Questions
The factors that are driving the growth of market are increasing burden of periodontal diseases and oral cancer and increased market development activities in dental bone graft substitute and barrier membrane market. However, the high cost of products and delays in dental check-ups hinders the market growth.
The dental bone graft substitute and barrier membrane market majorly consists of the players such as Geistlich Pharma AG, Medtronic Plc, Dentsply Sirona Inc, Matricel GmbH, ZimVie Inc, Regenity Biosciences Inc, Neoss UK & Ireland Ltd, Institut Straumann AG, CAMLOG Biotechnologies GmbH, and Resorba Medical GmbH.
Dental bone graft substitute and barrier membrane are used for periodontal disease and oral cancer patients in dental bone regeneration procedures. Dental membranes are used in combination with dental bone grafts to promote cell proliferation during the regeneration process. A bone graft is a material that can be implanted and used to promote bone formation, bone healing, skeletal reconstruction, and other procedures. These bone graft materials are used in bone grafting surgical procedures to replace damaged or missing bone (bone graft).
The List of Companies - Dental Bone Graft Substitute and Barrier Membrane Market
- Geistlich Pharma AG
- Medtronic Plc
- Dentsply Sirona Inc.
- Matricel GmbH
- ZimVie Inc.
- Regenity Biosciences Inc.
- Neoss UK & Ireland Ltd
- Institut Straumann AG
- CAMLOG Biotechnologies GmbH
- Resorba Medical GmbH
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Dental Bone Graft Substitutes and Barrier Membrane Market

Aug 2023
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

Aug 2023
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography

Aug 2023
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)

Aug 2023
Coagulation Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease Indications (Vitamin K Deficiency, Liver Disease, Disseminated Intravascular Coagulation & Pulmonary Embolism, Development of Circulating Anticoagulants, Hemophilia, Von Willebrand's Disease, and Others), Type [Clinical Laboratory Analyzers (Controls & Calibrators, Assays & Reagents, Instruments/Systems, Coagulation Factors, and Others) and Point-of-Care Testing Analyzers], Offering [Diagnosis (Prothrombin Time Testing, Fibrinogen Testing, Activated Clotting Time Testing, Activated Partial Thromboplastin Time Testing, D-Dimmer Testing, Platelets Function Testing, and Others) and Treatment (Anti-Fibrinolytic Drugs, Birth Control Pills, Desmopressin & Immunosuppressive Medicines, Vitamin K Supplements, Blood Thinners, Thrombin Inhibitors or Thrombolytics, Replacement Therapy, Catheter-Assisted Thrombus Removal, and Others)], Technology (Optical Technology, Mechanical Technology, Electrochemical Technology, and Others), End User (Clinical Laboratories, Hospitals, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)

Aug 2023
Pharmacy Automation Systems Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Automation Medication Dispensing Systems (Product Type and Operation), Automated Packaging and Labelling Systems, Automated Table-Top Counters, Automated Storage and Retrieval Systems, and Other Types], End User (Hospital Pharmacy, Retail Pharmacy, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

Aug 2023
DNA Extraction, Isolation, and Purification Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type (Kits, Instruments, and Reagents), Method (Chemical Method and Physical Method), Sample Type (Blood, Body Fluids, and Others), Source (Genomic DNA and Microbial DNA), Application [PCR Test, Next Generation Sequencing (NGS), Microarray, and Others], End User (Hospitals, Diagnostic Centers and Research Laboratories, Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East and Africa and South and Central America)

Aug 2023
Molecular Diagnostic for Infectious Diseases Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type (Point-of-Care Testing and Laboratory Testing), End User [Point-of-Care Testing (Human Testing and Vet Testing) and Laboratory Testing (Human Testing and Vet Testing)], Application [Point-of-Care Testing (Detection of Single Pathogen, Detection of Two or More Pathogens, Evaluation of Emerging Novel Infections, Surveillance and Early Detection of Biothreat Agents and Diseases-Related Biomarker, and Antimicrobial Resistance Profiling) and Laboratory Testing (Patient stratification, Drug Regimen Selection, Toxicity Avoidance, Therapeutic Monitoring, and Detection of Predisposition to Disease)], Disease Type [Point-of-Care Testing (Sepsis, Prosthetic Joint Infection, Endocarditis, STDs, Mononucleosis, Group A Streptococcus, and Others) and Laboratory Testing (Sepsis, Prosthetic Joint infection, Endocarditis, STDs, Chlamydia, Gastrointestinal Infection, Tuberculosis, H1N1 Virus, and Others)], Infection Type [Point-of-Care Testing (Bacteria, Viral, Fungi, and Others) and Laboratory Testing (Bacteria, Viral, Fungi, and Others)], and Geography (North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa)

Aug 2023
Bovine Diagnostics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Immunoassay Kits, PCR Reagents & Kits, Hemagglutination Inhibition (HI) Assay, and Other Products), Disease Type [Bovine Viral Diarrhea (BVD), Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Types], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography